Seeing Is Believing
Currently, out of the existing stock ratings of Cory Kasimov - 74 which are a Buy (76.29%), 20 which are a Hold (20.62%), 3 which are a Sell (3.09%)
Analyst Cory Kasimov works at JPMORGAN and is covering the Healthcare sector with 219 price targets and ratings displayed on 25 stocks.
Cory Kasimov's average stock forecast success ratio is 65.61% with an average time for price targets to be met of 327.36 days.
Most recent stock forecast was given on KRTX, Karuna Therapeutics at 05-Jun-2023.
Analyst best performing recommendations are on EDIT (EDITAS MEDICINE).
The best stock recommendation documented was for EDIT (EDITAS MEDICINE) at 2/29/2016. The price target of $32 was fulfilled within 3 days with a profit of $3.05 (10.54%) receiving and performance score of 35.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
30
$4.42 (17.28%)
30
1 months 25 days ago
14/20 (70%)
$6 (20.78%)
165
Buy
38
$12.42 (48.55%)
26
1 months 25 days ago
15/18 (83.33%)
$7.65 (27.96%)
182
Buy
33
$7.42 (29.01%)
33
1 months 25 days ago
9/13 (69.23%)
$8.33 (34.09%)
122
Hold
25
$-0.58 (-2.27%)
25
1 months 25 days ago
10/12 (83.33%)
$-0.47 (0.44%)
40
Buy
33
$7.42 (29.01%)
27
2 months 14 days ago
10/16 (62.5%)
$9.2 (38.05%)
224
Which stock is Cory Kasimov is most bullish on?
What Year was the first public recommendation made by Cory Kasimov?